Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.
Funding
Alexandria Venture Investments, the venture capital arm of real estate investment trust Alexandria Real Estate Equities, took part in a $76m series A round yesterday for Pheast Therapeutics, a US-based cancer drug developer spun out of Stanford University. Catalio Capital Management and Arch Venture Partners co-led the round, which also featured Risk and Reward and, according to MedCity News, Stanford University’s Presidential Venture Fund.
US-headquartered token exchange technology developer 0x Labs secured $70m in series B funding yesterday from investors including non-fungible token marketplace OpenSea, digital currency exchange Coinbase and Jump Crypto, a subsidiary of trading firm Jump Trading. VC firm Greylock led the round, which was also backed by Pantera Capital, Sound Ventures, A.Capital, Brevan Howard and private investors Reid Hoffman and Jared Leto.
Singapore-headquartered music creation tool provider BandLab completed a $65m series B round yesterday featuring Prosus Ventures, the investment arm of e-commerce and internet holding…
